TY - JOUR
T1 - The Global Virus Network
T2 - Challenging chikungunya
AU - McSweegan, Edward
AU - Weaver, Scott C.
AU - Lecuit, Marc
AU - Frieman, Matthew
AU - Morrison, Thomas E.
AU - Hrynkow, Sharon
PY - 2015/6/23
Y1 - 2015/6/23
N2 - Abstract The recent spread of chikungunya virus to the Western Hemisphere, together with the ongoing Ebola epidemic in West Africa, have highlighted the importance of international collaboration in the detection and management of disease outbreaks. In response to this need, the Global Virus Network (GVN) was formed in 2011. The GVN is a coalition of leading medical virologists in 34 affiliated laboratories in 24 countries, who collaborate to share their resources and expertise. The GVN supports research, promotes training for young scientists, serves as a technical resource for governments, businesses and international organizations, facilitates international scientific cooperation, and advocates for funding and evidence-based public policies. In response to the spread of chikungunya, the GVN formed a task force to identify research gaps and opportunities, including models of infection and disease, candidate vaccines and antivirals, epidemiology and vector control measures. Its members also serve as authoritative sources of information for the public, press, and policy-makers. This article forms part of a symposium in Antiviral Research on "Chikungunya discovers the New World".
AB - Abstract The recent spread of chikungunya virus to the Western Hemisphere, together with the ongoing Ebola epidemic in West Africa, have highlighted the importance of international collaboration in the detection and management of disease outbreaks. In response to this need, the Global Virus Network (GVN) was formed in 2011. The GVN is a coalition of leading medical virologists in 34 affiliated laboratories in 24 countries, who collaborate to share their resources and expertise. The GVN supports research, promotes training for young scientists, serves as a technical resource for governments, businesses and international organizations, facilitates international scientific cooperation, and advocates for funding and evidence-based public policies. In response to the spread of chikungunya, the GVN formed a task force to identify research gaps and opportunities, including models of infection and disease, candidate vaccines and antivirals, epidemiology and vector control measures. Its members also serve as authoritative sources of information for the public, press, and policy-makers. This article forms part of a symposium in Antiviral Research on "Chikungunya discovers the New World".
KW - Arbovirus
KW - Chikungunya
KW - Emerging virus
KW - Global Virus Network
KW - Vector-borne
UR - http://www.scopus.com/inward/record.url?scp=84934957173&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84934957173&partnerID=8YFLogxK
U2 - 10.1016/j.antiviral.2015.06.003
DO - 10.1016/j.antiviral.2015.06.003
M3 - Review article
C2 - 26071007
AN - SCOPUS:84934957173
SN - 0166-3542
VL - 120
SP - 147
EP - 152
JO - Antiviral research
JF - Antiviral research
M1 - 3643
ER -